Financials
Financial year 2025
BioCeriX from Rumst, company number BE0807873804, closed financial year 2025 with a result of € 270,338 after tax. For that financial year BioCeriX recorded a gross margin of € 167,115 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 417,322 to € 270,338. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.
€ 1.3 million
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 270,338
▼ 35% vs 2024
Profit after tax over the fiscal year.
€ 184,443
▼ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 329,251 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 18,351
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 134,632
▼ 20% vs 2024
€ 34,911 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 3,015
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,182
▲ 238% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 123,482 | € 162,801 | € 151,886 | € 167,115 | ▲ 10% |
| Profit after taxes | € 226,961 | € 437,902 | € 417,322 | € 270,338 | ▼ 35% |
| Equity | € 830,517 | € 959,022 | € 1,376,344 | € 1,317,431 | ▼ 4% |
| Total debts | € 259,295 | € 506,453 | € 185,671 | € 171,795 | ▼ 7% |
| Cash | € 402,652 | € 778,114 | € 232,991 | € 184,443 | ▼ 21% |
| Land & buildings | € 541,049 | € 512,371 | € 488,221 | € 466,054 | ▼ 5% |
| Retained profit | € 811,917 | € 940,422 | € 1,357,744 | € 1,298,831 | ▼ 4% |
| Dividend | € 100,000 | € 309,397 | € 0 | € 329,251 | |
| Bank debt | € 234,721 | € 202,114 | € 168,757 | € 134,632 | ▼ 20% |
| Balance sheet total | € 1,089,812 | € 1,465,475 | € 1,562,015 | € 1,489,226 | ▼ 5% |
Key figures of BioCeriX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BioCeriX?
What happened at BioCeriX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 270,338 (▼ 35% vs 2024). Source: NBB ↗
- New establishment in Boom. KBO
- New establishment in Boom. KBO
- Start of the company according to the CBE. KBO
- New establishment in Rumst. KBO
- Kris Van Assche became a director. NBB
In short
From € 226,961 profit in 2022 to € 270,338 profit in 2025.
Paid € 197,230 in corporate taxes since 2022.
Best year ever: 2023, with € 437,902 profit.
Paid out € 738,648 in dividends to the owners in total.
A new publication or filing at BioCeriX? We notify you, reason included.
Follow BioCeriXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BioCeriX is Kris Van Assche. It owns 100% of NODIA BV (NL) itself.
Directors
According to the 2025 annual accounts
Kris Van Assche
Director
since 2008
Establishments
Establishment units
Physical locations of this company
Hoveniersstraat 27
2840 Rumst
Scherpenhoek 10
2850 Boom
Active since 1 May 2015
Noeveren 56+ box 30
2850 Boom
Active since 1 July 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0807.873.804
- VAT number
- BE 0807.873.804
- Registered office
- Hoveniersstraat 27, 2840 Rumst
- Names & denominations
- BioCeriX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 November 2008
- Peppol
- Active · Active since 29 Apr 2026
- Contact
- [email protected]
- Activities · NACE
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Markt- en opinieonderzoek
Vervaardiging van overige farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Overige vormen van onderwijs
Overige dienstverlenende activiteiten op het gebied van informatie
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.